AstraZeneca PLC (STO: AZN)
Sweden
· Delayed Price · Currency is SEK 1,433.00
+10.00 (0.70%)
Dec 20, 2024, 5:29 PM CET
AstraZeneca Revenue
AstraZeneca had revenue of $13.57B USD in the quarter ending September 30, 2024, with 18.04% growth. This brings the company's revenue in the last twelve months to $51.21B, up 13.81% year-over-year. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.
Revenue (ttm)
$51.21B
Revenue Growth
+13.81%
P/S Ratio
n/a
Revenue / Employee
$569.59K
Employees
89,900
Market Cap
2,202.72B SEK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
| Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
| Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
| Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
| Dec 31, 2019 | 24.38B | 2.29B | 10.38% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Medicover AB (publ) | 22.60B |
| Vitrolife AB (publ) | 3.56B |
| Bonesupport Holding AB (publ) | 814.46M |
| Elekta AB (publ) | 17.72B |
AstraZeneca News
- 11 hours ago - AZN STOCK ALERT: Levi & Korsinsky Notifies AstraZeneca PLC Investors of an Ongoing Investigation - Accesswire
- 1 day ago - AstraZeneca's (AZN) New Obesity Drug AZD6234 Approved for Clinical Trials in China - GuruFocus
- 2 days ago - Beijing Woos AstraZeneca for Investment While Probe Continues - BNN Bloomberg
- 2 days ago - ATTENTION AZN SHAREHOLDERS: Investors who Lost Money on AstraZeneca PLC are Urged to Contact Levi & Korsinsky about an Ongoing Investigation - Accesswire
- 2 days ago - AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC - Accesswire
- 2 days ago - AstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens Berman - GlobeNewsWire
- 3 days ago - AstraZeneca Digital Transformation Strategy Profile 2024 - Accelerators, Incubators and Innovation Programs - GlobeNewsWire
- 3 days ago - AstraZeneca PLC (AZN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire